GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Albert Labs International Corp (XCNQ:ABRT) » Definitions » Gross-Profit-to-Asset %

Albert Labs International (XCNQ:ABRT) Gross-Profit-to-Asset % : 0.00% (As of Sep. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Albert Labs International Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Albert Labs International's annualized Gross Profit for the quarter that ended in Sep. 2023 was C$0.00 Mil. Albert Labs International's average Total Assets over the quarter that ended in Sep. 2023 was C$0.07 Mil. Therefore, Albert Labs International's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2023 was 0.00%.


Albert Labs International Gross-Profit-to-Asset % Historical Data

The historical data trend for Albert Labs International's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert Labs International Gross-Profit-to-Asset % Chart

Albert Labs International Annual Data
Trend Dec21 Dec22
Gross-Profit-to-Asset %
- -

Albert Labs International Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Albert Labs International's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Albert Labs International's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Albert Labs International's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Albert Labs International's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Albert Labs International's Gross-Profit-to-Asset % falls into.



Albert Labs International Gross-Profit-to-Asset % Calculation

Albert Labs International's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2022 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2022 )/( (Total Assets (A: Dec. 2021 )+Total Assets (A: Dec. 2022 ))/ count )
=0/( (0.358+0.164)/ 2 )
=0/0.261
=0.00 %

Albert Labs International's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Sep. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Sep. 2023 ))/ count )
=0/( (0.071+0.065)/ 2 )
=0/0.068
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Sep. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Albert Labs International Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Albert Labs International's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Albert Labs International (XCNQ:ABRT) Business Description

Traded in Other Exchanges
N/A
Address
6996, Merritt Avenue, Burnaby, BC, CAN, V5J 4R6
Albert Labs International Corp is a laboratory-based, clinical research and drug development enterprise addressing mental health care needs. The company is focusing on Real World Evidence (RWE) the company will initially look to commercialize its mycelium-based KRN-101 medicine and treatment with the help of clinical pathway.

Albert Labs International (XCNQ:ABRT) Headlines

No Headlines